AD Pipeline Update: Turn Therapeutics Launches Trial Evaluating Its Topical IL-36/IL-31 Inhibitor for Eczema July 15, 2025
GW Dermatology Scores Grant to Evaluate the Effectiveness of Atopic Triad Screening in Underserved Populations July 10, 2025
Tralokinumab (Adbry, Leo Pharma) Shows Efficacy and Safety in Moderate-to-Severe Hand AD July 9, 2025
Hawaii Tops List of States With the Most Google Searches for Skin Conditions and Treatments July 8, 2025
